XLV, the Health Care Select Sector SPDR ETF, has flipped the script from last week — short sellers are back, rebuilding positions at pace even as the ETF climbs to $175.29, up 3.3% on the week and nearly 8% over the past month.
The short interest reversal is the standout development. Just seven days ago, a prior note flagged shorts retreating and SI sitting at 5.2% of free float. That covering trend has now reversed sharply. Short interest has climbed 15.8% over the past week to 5.95% of free float, erasing most of the mid-August decline. The ORTEX short score has tracked that rebuilding: it stood at 44.5 on August 14 and has climbed to 54.5 by August 25 — a meaningful 10-point swing in less than two weeks. This isn't residual positioning; it's an active rebuild against a rising tape.
The borrow market adds texture to the short-side story, though it remains far from stressed. Availability has tightened sharply — from above 340% two weeks ago to 122% now — meaning the lending pool has absorbed significantly more demand as new shorts opened. Cost to borrow is up 38% on the week but remains very low at 0.58%. That combination — tightening availability, rising borrow cost, rising SI — points to genuine fresh short demand rather than technical noise. The 52-week availability low is 24%, so there is ample room for borrow conditions to tighten further if this rebuild continues.
Options positioning remains structurally defensive, and that consistency matters. The put/call ratio is 1.43, a touch above the 20-day average of 1.37 and about one standard deviation elevated — not extreme, but persistent. Every session since early August has logged a PCR above the July average. That drift has now held across two full weeks and through a 3% rally in the underlying. Investors are not letting up on downside protection even as the ETF makes new highs. The contrast with the short-side story is no longer a divergence — both are now pointing in the same cautious direction, just through different instruments.
The institutional ownership picture is broadly stable. As of June 30, the largest single holder is Managed Account Advisors with 9% of shares. JPMorgan trimmed its position by roughly 2.7 million shares in the quarter, while Goldman Sachs added 1.3 million — the most notable divergence among the big names. These flows predate the current short rebuild and may say more about Q2 rotation than current conviction.
The next development to watch is whether availability continues to tighten toward the 52-week low of 24% — if short demand keeps building against a still-rising ETF, the gap between defensive options positioning and a climbing price becomes increasingly difficult to hold.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
